Advertisement

Current Colorectal Cancer Reports

, Volume 14, Issue 6, pp 266–273 | Cite as

The Role of Energy Balance on Colorectal Cancer Survival

  • Sarah A. Purcell
  • Jingjie Xiao
  • Katherine L. Ford
  • Carla M. Prado
Nutrition and Nutritional Interventions in Colorectal Cancer (K Wu, Section Editor)
  • 42 Downloads
Part of the following topical collections:
  1. Topical Collection on Nutrition and Nutritional Interventions in Colorectal Cancer

Abstract

Purpose of Review

Body weight and body composition (i.e., skeletal muscle and adipose tissue) are indicators of long-term energy balance and substrate metabolism. The objective of the current review was to describe the role of energy balance on survival and the potential mechanisms of this relationship in patients with colorectal cancer (CRC).

Recent Findings

Energy balance consists of total energy expenditure and dietary intake over time, although these components have been sparsely characterized in CRC. Several large trials have suggested that BMI around 28 kg/m2 at diagnosis is most advantageous for survival and that severe weight loss (i.e., body mass index loss ≥ 7% or ≥ 10% baseline weight) is associated with poor survival. These patterns are likely due to skeletal muscle. Higher skeletal muscle mass is associated with improved survival, although the relative impact is mediated by sex and adipose tissue. Inflammation, physical inactivity, anti-cancer therapy, altered amino acid metabolism, and co-morbidities accelerate loss of muscle mass in people with cancer. Low muscle mass and muscle mass loss represent impaired physiological reserves which impact physical function, anti-cancer therapy toxicities, increased infection rates, and shorter survival. Higher visceral adipose tissue negatively impacts survival, possibly because it is associated with metabolic derangements such as systemic inflammation, insulin resistance, and adipokine secretion.

Summary

Body weight and composition are important prognostic factors for CRC survival. An improved understanding of the mechanisms driving energy imbalance is warranted, with translation to optimal interventions for improving overall health and survival.

Keywords

Colorectal cancer Body weight Obesity Body composition Energy balance 

Notes

Compliance with Ethical Standards

Conflict of Interest

Sarah A. Purcell declares that she has no conflict of interest. Jingjie Xiao declares that she has no conflict of interest. Katherine L. Ford declares that she has no conflict of interest. Carla M. Prado is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Salary Award and the Campus Alberta Innovates Program.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556–65.CrossRefGoogle Scholar
  2. 2.
    Society; AC. Does body weight affect cancer risk? 2018 [Available from: https://www.cancer.org/cancer/cancer-causes/diet-physical-activity/body-weight-and-cancer-risk/effects.html].
  3. 3.
    • Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, et al. Association of weight change after colorectal cancer diagnosis and outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017;26(1):30–7 A study in 2781 patients with stages I–III CRC which showed that weight loss after diagnosis was associated with worse survival and was not caused by reverse causality. CrossRefGoogle Scholar
  4. 4.
    Kocarnik JM, Hua X, Hardikar S, Robinson J, Lindor NM, Win AK, et al. Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: the colon cancer family registry. Cancer. 2017;123(23):4701–8.CrossRefGoogle Scholar
  5. 5.
    Park YS, Park DJ, Lee Y, Park KB, Min S-H, Ahn S-H, et al. Prognostic roles of perioperative body mass index and weight loss in the long-term survival of gastric cancer patients. Cancer Epidemiol Biomark Prev. 2018.Google Scholar
  6. 6.
    Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33(1):90–9.CrossRefGoogle Scholar
  7. 7.
    Prado CM, Cushen SJ, Orsso CE, Ryan AM. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc Nutr Soc. 2016:1–11.Google Scholar
  8. 8.
    Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: IARC CancerBase no. 11. Lyon, France: World Health Organization 2012.Google Scholar
  9. 9.
    Jochem C, Leitzmann M. Obesity and colorectal Cancer. Recent Results Cancer Res. 2016;208:17–41.CrossRefGoogle Scholar
  10. 10.
    Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Birdsell L, et al. The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl). 2012;21(4):505–16.CrossRefGoogle Scholar
  11. 11.
    Xiao J, Caan BJ, Weltzien E, Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, et al. Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer. J Cachexia Sarcopenia Muscle. 2018.Google Scholar
  12. 12.
    Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(suppl_2):ii1–ii9.Google Scholar
  13. 13.
    Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr. 2012;31(5):583–601.CrossRefGoogle Scholar
  14. 14.
    Cao DX, Wu GH, Zhang B, Quan YJ, Wei J, Jin H, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr. 2010;29(1):72–7.CrossRefGoogle Scholar
  15. 15.
    Nguyen TYV, Batterham MJ, Edwards C. Comparison of resting energy expenditure between cancer subjects and healthy controls: a meta-analysis. Nutr Cancer. 2016;68(3):374–87.CrossRefGoogle Scholar
  16. 16.
    Johannsen DL, Calabro MA, Stewart J, Franke W, Rood JC, Welk GJ. Accuracy of armband monitors for measuring daily energy expenditure in healthy adults. Med Sci Sports Exerc. 2010;42(11):2134–40.CrossRefGoogle Scholar
  17. 17.
    Viggiani MT, Lorusso O, Natalizio F, Principi M, Di Leo A, Barone M. Influence of chemotherapy on total energy expenditure in patients with gastrointestinal cancer: a pilot study. Nutrition. 2017;42:7–11.CrossRefGoogle Scholar
  18. 18.
    clinicaltrials.gov. Identifier: NCT03131921. Resting Energy Expenditure in Cancer - Associations With Body Composition, Dietary Intake, and Exercise Habits Bethesda, MD: National Library of Medicine; 2017 [updated May 3, 2017.
  19. 19.
    Prado CM, Lieffers JR, Bergsten G, Mourtzakis M, Baracos VE, Reiman T, et al. Dietary patterns of patients with advanced lung or colorectal cancer. Can J Diet Pract Res. 2012;73(4):e298–303.CrossRefGoogle Scholar
  20. 20.
    Dray X, Boutron-Ruault MC, Bertrais S, Sapinho D, Benhamiche-Bouvier AM, Faivre J. Influence of dietary factors on colorectal cancer survival. Gut. 2003;52(6):868–73.CrossRefGoogle Scholar
  21. 21.
    Van Blarigan EL, Meyerhardt JA. Role of physical activity and diet after colorectal cancer diagnosis. J Clin Oncol. 2015;33(16):1825–34.CrossRefGoogle Scholar
  22. 22.
    •• Renfro LA, Loupakis F, Adams RA, Seymour MT, Heinemann V, Schmoll HJ, et al. Body mass index is prognostic in metastatic colorectal cancer: pooled analysis of patients from first-line clinical trials in the ARCAD database. J Clin Oncol. 2016;34(2):144–50 A pooled analysis of over 20,000 patients with metastatic CRC which showed that risk of disease progression and/or death decreased as BMI increased until approximately 28 kg/m 2 . CrossRefGoogle Scholar
  23. 23.
    Kroenke CH, Neugebauer R, Meyerhardt J, Prado CM, Weltzien E, Kwan ML, et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2016;2(9):1137–45.CrossRefGoogle Scholar
  24. 24.
    Lee J, Meyerhardt JA, Giovannucci E, Jeon JY. Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS One. 2015;10(3):e0120706.CrossRefGoogle Scholar
  25. 25.
    Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, et al. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. Br J Cancer. 2016;114(1):103–9.CrossRefGoogle Scholar
  26. 26.
    Pelser C, Arem H, Pfeiffer RM, Elena JW, Alfano CM, Hollenbeck AR, et al. Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP diet and health study. Cancer. 2014;120(10):1540–7.CrossRefGoogle Scholar
  27. 27.
    Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Dannenberg AJ, et al. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. J Clin Oncol. 2016.Google Scholar
  28. 28.
    Walter V, Jansen L, Hoffmeister M, Ulrich A, Roth W, Blaker H, et al. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer. Am J Clin Nutr. 2016;104(4):1110–20.CrossRefGoogle Scholar
  29. 29.
    Winkels RM, Snetselaar T, Adriaans A, van Warmerdam LJC, Vreugdenhil A, Slooter GD, et al. Changes in body weight in patients with colorectal cancer treated with surgery and adjuvant chemotherapy: an observational study. Cancer Treat Res Commun. 2016;9:111–5.CrossRefGoogle Scholar
  30. 30.
    Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z, et al. Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. J Cancer Res Clin Oncol. 2016;142(12):2551–60.CrossRefGoogle Scholar
  31. 31.
    Casas-Vara A, Santolaria F, Fernandez-Bereciartua A, Gonzalez-Reimers E, Garcia-Ochoa A, Martinez-Riera A. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition. 2012;28(6):616–22.CrossRefGoogle Scholar
  32. 32.
    Biasucci LM, Graziani F, Rizzello V, Liuzzo G, Guidone C, De Caterina AR, et al. Paradoxical preservation of vascular function in severe obesity. Am J Med. 2010;123(8):727–34.CrossRefGoogle Scholar
  33. 33.
    Schenkeveld L, Magro M, Oemrawsingh RM, Lenzen M, de Jaegere P, van Geuns RJ, et al. The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open. 2012;2:e000535.CrossRefGoogle Scholar
  34. 34.
    Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47.CrossRefGoogle Scholar
  35. 35.
    Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–47.CrossRefGoogle Scholar
  36. 36.
    Boer BC, de Graaff F, Brusse-Keizer M, Bouman DE, Slump CH, Slee-Valentijn M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Color Dis. 2016;31(6):1117–24.CrossRefGoogle Scholar
  37. 37.
    Choi MH, Oh SN, Lee IK, Oh ST, Won DD. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia Sarcopenia Muscle. 2018;9(1):53–9.CrossRefGoogle Scholar
  38. 38.
    Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103(5):572–80.CrossRefGoogle Scholar
  39. 39.
    van Vugt JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, Dekker JWT, Zimmerman DDE, et al. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol. 2018.Google Scholar
  40. 40.
    •• Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017;26(7):1008–15 This study included 3262 patients with stage I–III CRC; 42% had low muscle, which was associated with higher risk of overall mortality. Sex differences in body composition were also explored.CrossRefGoogle Scholar
  41. 41.
    Baar HV, Winkels RM, Posthuma L, Bours MJ, Weijenberg MP, Kampman E, et al. The association between total-, visceral- and subcutaneous adipose tissue and overall mortality in early-stage colorectal cancer patients. Clin Nutr. 2018;37:S84–S5.Google Scholar
  42. 42.
    Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM. Visceral adiposity and cancer survival: a review of imaging studies. Eur J Cancer Care (Engl). 2018;27(2):e12611.CrossRefGoogle Scholar
  43. 43.
    • Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, et al. Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2016. Muscle loss ≥ 9% was associated with poorer survival 6 months and 1 year after diagnosis in patients with stage IV CRC. Google Scholar
  44. 44.
    Levolger S, van Vledder MG, Alberda WJ, Verhoef C, de Bruin RWF, JNM IJ, et al. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma. Clin Nutr. 2017.Google Scholar
  45. 45.
    Choe EK, Park KJ, Ryoo S-B, Moon SH, Oh H-K, Han EC. Prognostic impact of changes in adipose tissue areas after colectomy in colorectal Cancer patients. J Korean Med Sci. 2016;31(10):1571–8.CrossRefGoogle Scholar
  46. 46.
    Durham WJ, Dillon EL, Sheffield-Moore M. Inflammatory burden and amino acid metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care. 2009;12(1):72–7.CrossRefGoogle Scholar
  47. 47.
    Malietzis G, Currie AC, Johns N, Fearon KC, Darzi A, Kennedy RH, et al. Skeletal muscle changes after elective colorectal cancer resection: a longitudinal study. Ann Surg Oncol. 2016;23:2539–47.CrossRefGoogle Scholar
  48. 48.
    Nicolini A, Ferrari P, Masoni MC, Fini M, Pagani S, Giampietro O, et al. Malnutrition, anorexia and cachexia in cancer patients: a mini-review on pathogenesis and treatment. Biomed Pharmacother. 2013;67(8):807–17.CrossRefGoogle Scholar
  49. 49.
    Romero SAD, Li QS, Mao JJ. Factors and barriers associated with changes in physical activity after cancer diagnosis. Journal or Clinical Oncology. 2017;35(supplement 5S):abstract 162.Google Scholar
  50. 50.
    Prado CMM, Lieffers JR, Bowthorpe L, Baracos VE, Mourtzakis M, McCargar LJ. Sarcopenia and physical function: in overweight patients with advanced cancer. Can J Diet Pract Res. 2013;74(2):69–74.CrossRefGoogle Scholar
  51. 51.
    Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2000;904:553–7.CrossRefGoogle Scholar
  52. 52.
    Aoyama T, Oba K, Honda M, Sadahiro S, Hamada C, Mayanagi S, et al. Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients’ data from three large phase III randomized trials. Cancer Medicine. 2017;6(7):1573–80.CrossRefGoogle Scholar
  53. 53.
    Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931–6.CrossRefGoogle Scholar
  54. 54.
    • Hopkins JJ, Sawyer MB. A review of body composition and pharmacokinetics in oncology. Expert Rev Clin Pharmacol. 2017;10(9):947–56 A thorough review of the literature that investigates the impact of body compoisiton in cancer treatment alterations. CrossRefGoogle Scholar
  55. 55.
    Prado CM, Antoun S, Sawyer MB, Baracos VE. Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity. Curr Opin Clin Nutr Metab Care. 2011;14(3):250–4.CrossRefGoogle Scholar
  56. 56.
    Park JS, Cho MH, Nam JS, Ahn CW, Cha BS, Lee EJ, et al. Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients. Acta Diabetol. 2010;47(2):113–8.CrossRefGoogle Scholar
  57. 57.
    Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005;28(9):2322–5.CrossRefGoogle Scholar
  58. 58.
    Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–56.CrossRefGoogle Scholar
  59. 59.
    Bjorge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, et al. Metabolic risk factors and ovarian cancer in the metabolic syndrome and Cancer project. Int J Epidemiol. 2011;40(6):1667–77.CrossRefGoogle Scholar
  60. 60.
    Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes. 2008;32(4):619–28.CrossRefGoogle Scholar
  61. 61.
    Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer. 2017;117(1):148–55.CrossRefGoogle Scholar
  62. 62.
    Paz-Filho G, Mastronardi C, Wong M-L, Licinio J. Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J Endocrinol Metab. 2012;16(Suppl 3):S549–S55.CrossRefGoogle Scholar
  63. 63.
    Malietzis G, Aziz O, Bagnall NM, Johns N, Fearon KC, Jenkins JT. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. Eur J Surg Oncol. 2015;41(2):186–96.CrossRefGoogle Scholar
  64. 64.
    Paris MT, Mourtzakis M, Day A, Leung R, Watharkar S, Kozar R, et al. Validation of bedside ultrasound of muscle layer thickness of the quadriceps in the critically ill patient (VALIDUM study): a prospective multicenter study. JPEN J Parenter Enteral Nutr. 2016.Google Scholar
  65. 65.
    Raeder H, Kvaerner AS, Henriksen C, Florholmen G, Henriksen HB, Bohn SK, et al. Validity of bioelectrical impedance analysis in estimation of fat-free mass in colorectal cancer patients. Clin Nutr. 2018;37(1):292–300.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Sarah A. Purcell
    • 1
  • Jingjie Xiao
    • 1
  • Katherine L. Ford
    • 1
  • Carla M. Prado
    • 1
  1. 1.Human Nutrition Research Unit, Department of Agricultural, Food, and Nutritional ScienceUniversity of AlbertaEdmontonCanada

Personalised recommendations